ArticleBMC biology2026
LAMB1 regulates COL3A1 and RAC1 expression during subchorionic hemorrhage progression.
Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
backgroundSubchorionic hemorrhage (SCH) is characterized by a fluid-filled hypoechoic area in early pregnancy. This study investigates how laminin subunit β1 (LAMB1) modulates type III collagen (COL3A1) and Rac family small GTPase 1 (RAC1) in SCH coagulation and immunity.
methodsWe recruited ten early-pregnancy SCH patients and ten gestational age-matched women undergoing elective abortion as controls. Proteomic and transcriptomic analyses were performed on decidua and villous tissues to identify differentially expressed proteins (DEPs) and genes (DEGs). Key biomarkers were screened using bioinformatics and machine learning algorithms (LASSO, SVM-RFE). An in vivo SCH-like model was established via LPS induction in pregnant rats, and in vitro experiments were conducted using HTR-8/SVneo trophoblast cells.
resultsProteomic analysis revealed enrichment in extracellular matrix and coagulation pathways, identifying LAMB1 as a central protein. Transcriptomic data confirmed upregulation of LAMB1 and COL3A1 and downregulation of RAC1 in SCH samples. Clinical blood analysis indicated coagulation abnormalities and Th1/Th2 imbalance in SCH patients. In vivo, LAMB1 knockdown alleviated inflammation, improved pregnancy outcomes, and restored Th2 cytokine expression. In vitro, LAMB1 silencing enhanced trophoblast proliferation, migration, and invasion while reducing pro-inflammatory cytokine levels. Mechanistically, LAMB1 modulated SCH progression via the COL3A1/RAC1 axis.
conclusionsLAMB1 promotes inflammation and coagulation dysfunction in SCH by regulating COL3A1 and RAC1 expression. Targeting LAMB1 may offer a novel strategy for early diagnosis and therapeutic intervention in SCH to improve pregnancy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.